Public Company News

Waterdrop Inc. to Report Second Quarter 2026 Financial Results on September 8, 2026

BEIJING, Aug. 25, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare services with a positive social impact, today announced that it will report its unaudited financial results for the second quarter ...

2026-08-25 18:00 1743

Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027

TAIPEI, Aug. 25, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced that it has completed enrollment in its Phase 1b expansion trial evaluating pidnarulex (CX-5461) monotherapy in patients with advanced solid tumors harboring BRCA1/2, PALB2, or other homologous recombinati...

2026-08-25 14:56 1354

Classys Nears 50,000 Devices Sold Globally as Full-Lineup Growth Accelerates

* Expands global portfolio beyond HIFU and MRF to include MNRF, laser, and dermabrasion devices, strengthening its medium- to long-term growth foundation * 1H26 Exports, excluding shipments to its Brazilian subsidiary, grew 29% year over year, underscoring continued growth across global market...

2026-08-25 12:26 1570

SCX.ai (ASX: SCX) Strategic Partnership With Global AI Leader DDN to Power Australia's Largest Sovereign AI Inferencing Cloud

Alliance to scale sovereign AI capacity as demand for Australian-based AI infrastructure grows SYDNEY, Aug. 24, 2026 /PRNewswire/ -- Australian sovereign AI infrastructure pioneer SCX.ai and global AI data intelligence leader DDN today announced a landmark...

2026-08-25 07:42 1469

Tuya Reports Second Quarter 2026 Unaudited Financial Results

SANTA CLARA, Calif., Aug. 24, 2026 /PRNewswire/ -- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391), a global leading AI cloud platform service provider, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter 2026 Financial Highlig...

2026-08-25 07:00 2367

WuXi XDC Delivers Strong First Half 2026 Performance, with Improving Margins and Profitability Further Strengthening Global ADC/XDC CRDMO Leadership

* Group total revenue increased to RMB 3,701.4 million, representing 37.0% period-over-period growth on an AER[1] basis (41.5% growth on a CER[2] basis) * Gross profit grew by 40.6% period-over-period, reaching RMB 1,371.3 million. Gross profit margin was 37.0%, a 0.9 percentage points increas...

2026-08-24 20:35 2704

Peijia Medical Announces 2026 Interim Results, Achieving First-Ever Profit Before Tax on Strong TAVR Growth

SUZHOU, China, Aug. 24, 2026 /PRNewswire/ -- Peijia Medical (9996.HK), a leading Chinese domestic company in the high-growth transcatheter valve therapeutics and neurovascular interventions markets, announced its interim results for the six months ended June 30, 2026 (the "Reporting Period") on ...

2026-08-24 20:00 2518

XPENG Reports Second Quarter 2026 Unaudited Financial Results

* Cash position[i] was RMB40.48 billion (US$5.97 billion) as of June 30, 2026 * Quarterly total revenues were RMB19.74 billion, a 51.5% increase quarter-over-quarter * Quarterly gross margin was 20.7%, an increase of 3.4 percentage points over the same period of 2025 * Quarterly vehicle ma...

2026-08-24 18:30 2835

SU Group Secures Exclusive Macao Rights for Award-Winning Robotic Infrastructure Inspection Solution

New partnership expands SU Group's technology portfolio, strengthens its newly established Macao operation and creates a platform for broader geographic growth HONG KONG, Aug. 24, 2026 /PRNewswire/ -- SU Group Holdings Limited (Nasdaq: SUGP) ("SU Group" or the "Company"), an integrated security-r...

2026-08-24 18:00 2247

X Financial Reports Second Quarter 2026 Unaudited Financial Results

SHENZHEN, China, Aug. 24, 2026 /PRNewswire/ -- X Financial (NYSE: XYF), a leading Chinesefintech platform, today announced its unaudited financial results for the second quarter ended June 30, 2026. This press release should be read in conjunction with the Company's Report on Form 6-K for the sec...

2026-08-24 17:50 2339

ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"

* Development of Leptin receptor-based technology and hybrid LNP platform * Combining Blood-Brain Barrier penetration and a one-month sustained-release formulation in a single structure, with potential applications in CNS-targeted therapeutics * Technology validated by winning first place in...

2026-08-24 15:01 1509

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy

* HM17321, a proprietary UCN2 (urocortin-2) analog, is being developed as a treatment for chronic-weight management and associated conditions, including obesity * Total deal value of up to $2.3 billion, including upfront, milestone payments and tiered royalties based on net sales SEOUL, South...

2026-08-24 12:40 1585

Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics

SEONGNAM, South Korea, Aug. 23, 2026 /PRNewswire/ -- Rznomics Inc.(KOSDAQ: 476830), a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that it is joining Lilly Gateway Labs (LGL) in San Diego, California. Lilly Gateway Labs is a best-in-class innov...

2026-08-24 09:54 4130

WiMi's Next-Generation Quantum Convolutional Neural Network Reshapes Classical Data Classification Methods

BEIJING, Aug. 21, 2026 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, proposes a cutting-edge quantum machine learning technology oriented toward classical data classification tasks—a quant...

2026-08-21 22:40 17330

Coreline Soft and INFINITT North America Deploy Chest CT-Based AI Reading Workflow at St. Joseph's Health

PHILLIPSBURG, N.J. and ATLANTA, Aug. 21, 2026 /PRNewswire/ -- Coreline Soft,

2026-08-21 21:00 5451

LightInTheBox to Report Second Quarter 2026 Financial Results on Wednesday, August 26, 2026

SINGAPORE, Aug. 21, 2026 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company, today announced that it will release its unaudited financial results for the second quarter ended June 30, 2026 before the open of U.S. ma...

2026-08-21 19:00 17578

Lanvin Group to Report 2026 First Half Results on August 26, 2026

SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its unaudited results for the first half of 2026 on Wednesday, August 26, 2026. On the same day, at 8:00 a.m. Eastern Standard Time (8:00 p.m. China Standard Time), the Grou...

2026-08-21 18:00 2580

ZKH Group Limited Announces Second Quarter 2026 Unaudited Financial Results

SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair, and operations ("MRO") procurement service platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2026. Second Quarter ...

2026-08-21 18:00 3678

Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) NDA Accepted by NMPA, Poised to Become World's First Approved 4-1BB-Targeting Therapy

NANJING, China, Aug. 21, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) has accepted the New Drug Application (NDA) for Op...

2026-08-21 17:20 2355

Dizal to Present Emerging Data on ZEGFROVY® in Non-Small Cell Lung Cancer at WCLC 2026

SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- Dizal (SSE: 688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that the latest clinical data on its novel epidermal growth factor receptor (EGFR) inhibitor ZE...

2026-08-21 16:03 2338
1 ... 891011121314 ... 752